Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.
Kim YS, Jeon SH, Kim J, Koh JH, Ra SW, Kim JW, Kim Y, Kim CK, Shin YC, Kang BD, Kang SJ, Park CH, Lee B, Lee JY, Lee CH, Choi JP, Kim JY, Yu SN, Peck KR, Kim SH, Heo JY, Kim HA, Park HJ, Choi J, Han J, Kim J, Kim HJ, Han SH, Yoon A, Park M, Park S, Kim Y, Jung M, Oh MD. Kim YS, et al. Among authors: kim jy, kim hj, kim sh, kim ck, kim ha, kim j, kim y, kim jw. Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0045222. doi: 10.1128/aac.00452-22. Epub 2022 Dec 14. Antimicrob Agents Chemother. 2023. PMID: 36515544 Free PMC article. Clinical Trial.
Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.
Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM, Chung YS, Kim HM, Han MG, Kim SY, Chin BS. Kim JY, et al. Among authors: kim yj, kim jm, kim hm, kim sy, kim y. J Korean Med Sci. 2020 Feb 24;35(7):e86. doi: 10.3346/jkms.2020.35.e86. J Korean Med Sci. 2020. PMID: 32080991 Free PMC article.
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection.
Kim JY, Jang YR, Hong JH, Jung JG, Park JH, Streinu-Cercel A, Streinu-Cercel A, Săndulescu O, Lee SJ, Kim SH, Jung NH, Lee SG, Park JE, Kim MK, Jeon DB, Lee YJ, Kim BS, Lee YM, Kim YS. Kim JY, et al. Among authors: kim bs, kim sh, kim ys, kim mk. Clin Ther. 2021 Oct;43(10):1706-1727. doi: 10.1016/j.clinthera.2021.08.009. Epub 2021 Aug 23. Clin Ther. 2021. PMID: 34551869 Free PMC article. Clinical Trial.
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019.
Streinu-Cercel A, Săndulescu O, Preotescu LL, Kim JY, Kim YS, Cheon S, Jang YR, Lee SJ, Kim SH, Chang I, Suh JH, Lee SG, Kim MR, Chung DR, Kim HN, Streinu-Cercel A, Eom JS. Streinu-Cercel A, et al. Among authors: kim jy, kim sh, kim mr, kim hn, kim ys. Open Forum Infect Dis. 2022 Feb 2;9(4):ofac053. doi: 10.1093/ofid/ofac053. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35295819 Free PMC article.
Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.
Kim H, Jang YR, Lee JY, Ko JH, Lee JY, Cho S, Lee YD, Song J, Hyun M, Kim HA, Hwang S, Ryou S, Na YJ, Lee JY, Lee C, Lee NY, Shin S, Kwon KT, Kim JY, Peck KR. Kim H, et al. Among authors: kim jy, kim ha. Front Cell Infect Microbiol. 2023 May 15;13:1192512. doi: 10.3389/fcimb.2023.1192512. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37256107 Free PMC article.
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea.
Lee JY, Bu SH, Song E, Cho S, Yu S, Kim J, Kym S, Seo KW, Kwon KT, Kim JY, Kim S, Ahn K, Jung N, Lee Y, Jung Y, Hwang C, Park SW. Lee JY, et al. Among authors: kim jy, kim s, kim j. Infect Dis Ther. 2023 Oct;12(10):2417-2435. doi: 10.1007/s40121-023-00859-1. Epub 2023 Oct 13. Infect Dis Ther. 2023. PMID: 37833467 Free PMC article.
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.
Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, Oh DH, Kim JH, Koh B, Kim SE, Yun NR, Lee JH, Kim JY, Kim Y, Bang JH, Song KH, Kim HB, Chung KH, Oh MD; Korea National Committee for Clinical Management of COVID-19. Kim ES, et al. Among authors: kim jy, kim se, kim hb, kim nj, kim y, kim jh. J Korean Med Sci. 2020 Apr 6;35(13):e142. doi: 10.3346/jkms.2020.35.e142. J Korean Med Sci. 2020. PMID: 32242348 Free PMC article.
Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea, January-May 2020.
Sung HK, Kim JY, Heo J, Seo H, Jang YS, Kim H, Koh BR, Jo N, Oh HS, Baek YM, Park KH, Shon JA, Kim MC, Kim JH, Chang HH, Park Y, Kang YM, Lee DH, Oh DH, Park HJ, Song KH, Lee EK, Jeong H, Lee JY, Ko JY, Choi J, Ryu EH, Chung KH, Oh MD; Korea National Committee for Clinical Management of COVID-19. Sung HK, et al. Among authors: kim jy, kim h, kim mc, kim jh. J Korean Med Sci. 2020 Aug 3;35(30):e280. doi: 10.3346/jkms.2020.35.e280. J Korean Med Sci. 2020. PMID: 32743995 Free PMC article.
12,193 results
You have reached the last available page of results. Please see the User Guide for more information.